HEALTH POLICY BRIEF — Friday, August 14

Executive Briefing

An ONC-backed study gives physician-burden advocates a useful reality check on electronic prior authorization. Among 8,419 family physicians, more than three-quarters reported at least one substantial administrative burden and 15% reported the full “triple burden” of chasing external information, prior authorization, and after-hours documentation. Better EHR support for external information helped; merely being able to complete prior authorization in the EHR was not associated with lower prior-authorization burden. Digitizing a bad workflow remains, regrettably, a very efficient way to preserve it. Policy relevance: Federal implementation policy should measure end-to-end burden reduction, not just whether an electronic function exists. Physician policy angle: Prepare a short evidence insert for the next CMS or ONC engagement, pairing the study’s DOI with concrete workflow outcomes. Source: Journal of General Internal Medicine (https://link.springer.com/article/10.1007/s11606-026-10635-9)

HHS-OIG posted a fresh payer-accountability audit of Kansas Medicaid managed care. For CY 2023, none of the three MCOs supplied Kansas with a complete prior-authorization parity analysis. One plan denied outpatient out-of-network mental-health and substance-use requests at 34%, versus 22% for comparable medical and surgical requests. OIG says that gap indicates possible noncompliance; it does not prove a parity violation, and the audit did not measure physician workload or patient harm. Kansas agreed to all three oversight recommendations and reported corrective steps. Policy relevance: The report supports annual, data-backed parity testing rather than paperwork-only compliance. Physician policy angle: Monitor the remaining OIG state audits and CMS follow-up, then build a cross-state comparison of denial-data quality, four-class parity analyses, and corrective-action enforcement. Source: HHS-OIG report A-07-24-02842 (https://oig.hhs.gov/reports/all/2026/kansas-did-not-ensure-that-its-medicaid-managed-care-organizations-complied-with-mental-health-and-substance-use-disorder-parity-requirements-related-to-prior-authorization/)

Federal Health Policy Watch

FDA opened the next public phase of PDUFA reauthorization for FY 2028–2032. A hybrid meeting is set for September 16, with written comments due October 16 under docket FDA-2026-N-8163. This sits outside this publication’s core digital health policy focus, but the proposed commitment spans review capacity, real-world evidence, patient-experience data, information technology, and digital health tools. Physician policy angle: Route the notice to the drug-policy owner and ask whether a submission or meeting presence is planned; no standalone digital-health work product is needed unless a cross-portfolio issue emerges. Source: Federal Register (https://www.federalregister.gov/documents/2026/08/14/2026-16650/reauthorization-of-the-prescription-drug-user-fee-act-public-meeting-request-for-comments)

The FTC’s newly published regulatory agenda contained no health-specific action that cleared the relevance gate. The implementation monitor again flagged CMS prior-authorization, CMS burden-reduction, ONC regulatory, and TEFCA pages, but publisher dates were unchanged and the alerts have repeated across multiple days; no substantive policy delta was verified, so those signals were suppressed.

Congress / Standards / Coding

No fresh congressional, HL7/FHIR, X12, NCPDP, TEFCA, USCDI, CPT, or coding movement independently cleared the evidence/action gate this morning.

Signal Scan

The cached X scan completed with findings. Official ONC and HHS-OIG posts surfaced the two lead items above; both were checked against the underlying study or agency report before inclusion. Other social and trade-press leads did not add a fresh, primary-source policy development relevant to privacy, cyber, physician-led AI governance, or standards implementation.

Policy Action Implications

- Prepare: Add the ONC-backed study to electronic prior-authorization and interoperability talking points, emphasizing outcomes over capability checkboxes.

- Monitor: Add the Kansas audit to the payer-accountability watchlist and compare it with the next OIG state audit or CMS response.

- Route: Send the PDUFA VIII meeting notice to the drug-policy owner before September 16; comments close October 16.